BIOMAT Database Logo BIOMAT Database Logo

Antihypertensive and renal effects of acute and chronic therapy with a dihydropyridine Ca-antagonist in patients with different salt sensitivity. 1996

F Galletti, and P Strazzullo, and G Barba, and I Ferrara, and R Iacone, and F Stinga, and M Mancini
Department of Clinical and Experimental Medicine, Federico II, University of Naples Medical School, Italy.

We evaluated the effect of the dihydropyridine Ca-channel blocker nitrendipine on blood pressure (BP) and electrolyte urinary excretion after acute and chronic therapy in 33 patients with different NaCl sensitivity as assessed by a modification of the test of Grim and colleagues. Acute nitrendipine administration significantly reduced BP in the group as a whole, although the hypotensive effect was greater in patients with greater NaCl sensitivity; this difference was still evident after 1 month of chronic therapy. Furthermore, urinary sodium and calcium excretion significantly increased in the 3 h after nitrendipine administration during both acute and chronic therapy: these effects on electrolyte excretion were independent of the NaCl sensitivity of the subject.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009568 Nitrendipine A calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive. Balminil,Bay e 5009,Bayotensin,Baypresol,Baypress,Gericin,Jutapress,Nidrel,Niprina,Nitre AbZ,Nitre-Puren,Nitregamma,Nitren 1A Pharma,Nitren Lich,Nitren acis,Nitrend KSK,Nitrendepat,Nitrendi Biochemie,Nitrendidoc,Nitrendimerck,Nitrendipin AL,Nitrendipin Apogepha,Nitrendipin Atid,Nitrendipin Basics,Nitrendipin Heumann,Nitrendipin Jenapharm,Nitrendipin Lindo,Nitrendipin Stada,Nitrendipin beta,Nitrendipin-ratiopharm,Nitrendipino Bayvit,Nitrendipino Ratiopharm,Nitrensal,Nitrepress,Tensogradal,Trendinol,Vastensium,nitrendipin von ct,nitrendipin-corax,Nitre Puren,NitrePuren,Nitrendipin ratiopharm,Nitrendipinratiopharm,nitrendipin corax,nitrendipincorax
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

F Galletti, and P Strazzullo, and G Barba, and I Ferrara, and R Iacone, and F Stinga, and M Mancini
Antihypertensive effects of a new dihydropyridine calcium antagonist.
September 1986, Arzneimittel-Forschung,
F Galletti, and P Strazzullo, and G Barba, and I Ferrara, and R Iacone, and F Stinga, and M Mancini
The effects of acute and chronic dihydropyridine calcium antagonist therapy on baroreflex sensitivity: a re-analysis using the sequence method.
March 2000, Journal of human hypertension,
F Galletti, and P Strazzullo, and G Barba, and I Ferrara, and R Iacone, and F Stinga, and M Mancini
Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker.
September 1989, Japanese journal of pharmacology,
F Galletti, and P Strazzullo, and G Barba, and I Ferrara, and R Iacone, and F Stinga, and M Mancini
Acute, chronic and postwithdrawal antihypertensive and renal effects of amlodipine in hypertensive patients.
December 1991, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
F Galletti, and P Strazzullo, and G Barba, and I Ferrara, and R Iacone, and F Stinga, and M Mancini
[Acute and chronic respiratory effects of an alpha-beta antagonist with antihypertensive action].
June 1980, La Clinica terapeutica,
F Galletti, and P Strazzullo, and G Barba, and I Ferrara, and R Iacone, and F Stinga, and M Mancini
Metabolic effects of antihypertensive therapy with a calcium antagonist.
October 1988, The American journal of cardiology,
F Galletti, and P Strazzullo, and G Barba, and I Ferrara, and R Iacone, and F Stinga, and M Mancini
[Comparative eficacy of antihypertensive therapy in patients with arterial hypertension and various sensitivity to salt].
January 2010, Kardiologiia,
F Galletti, and P Strazzullo, and G Barba, and I Ferrara, and R Iacone, and F Stinga, and M Mancini
Renal protective effects of chronic exercise and antihypertensive therapy in hypertensive rats with chronic renal failure.
October 2001, Journal of hypertension,
F Galletti, and P Strazzullo, and G Barba, and I Ferrara, and R Iacone, and F Stinga, and M Mancini
Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile.
November 1989, The American journal of cardiology,
F Galletti, and P Strazzullo, and G Barba, and I Ferrara, and R Iacone, and F Stinga, and M Mancini
Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist.
December 1986, Clinical pharmacology and therapeutics,
Copied contents to your clipboard!